Compare · NXTS vs UAN
NXTS vs UAN
Side-by-side comparison of Nexentis Technologies Inc. (NXTS) and CVR Partners LP (UAN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NXTS and UAN operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- UAN is the larger of the two at $1.27B, about 382.6x NXTS ($3.3M).
- Over the past year, NXTS is down 96.7% and UAN is up 30.0% - UAN leads by 126.7 points.
- NXTS has been more active in the news (6 items in the past 4 weeks vs 1 for UAN).
PerformanceNXTS-96.68%UAN+30.01%
2025-07-21+0.00%2026-07-20
- Company
- Nexentis Technologies Inc.
- CVR Partners LP
- Price
- $2.17-14.09%
- $117.09-0.76%
- Market cap
- $3.3M
- $1.27B
- 1M return
- -62.80%
- +4.05%
- 1Y return
- -96.68%
- +30.01%
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- NASDAQ
- NYSE
- IPO
- 2011
- News (4w)
- 6
- 1
- Recent ratings
- 0
- 0
UAN
CVR Partners LP
CVR Partners, LP, together with its subsidiaries, produces and distributes nitrogen fertilizer products in the United States. The company offers ammonia products for agricultural and industrial customers; and urea and ammonium nitrate products to agricultural customers, as well as retailers and distributors. CVR GP, LLC serves as the general partner of the company. CVR Partners, LP was founded in 2007 and is based in Sugar Land, Texas.
Latest NXTS
- SEC Form EFFECT filed by Nexentis Technologies Inc.
- SEC Form EFFECT filed by Nexentis Technologies Inc.
- SEC Form S-1 filed by Nexentis Technologies Inc.
- SEC Form POS AM filed by Nexentis Technologies Inc.
- Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative
- Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment
- SEC Form 424B5 filed by Nexentis Technologies Inc.
- Nexentis Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery
- Nexentis: Subsidiary MitoCareX Bio Successfully Completed Broad Analysis of SLC Transport Proteins to Support Discovery of Hard-to-Treat Cancers and Metabolic Diseases
Latest UAN
- CVR Partners to Release Second Quarter 2026 Earnings Results
- New insider Roberts Richard J. Jr. claimed ownership of 517 units of Common Units (SEC Form 3)
- CVR Partners 2025 Schedule K-3 Now Available
- CVR Energy and CVR Partners Announce Leadership Changes
- SEC Form 10-Q filed by CVR Partners LP
- CVR Partners LP filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- CVR Partners Reports First Quarter 2026 Results
- CVR Partners to Release First Quarter 2026 Earnings Results
- SEC Form 3 filed by new insider Turbidy Trevor
- CVR Partners LP filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits